VAERS reports by lot

Merck HPV lot 1687292: VAERS reports

59 VAERS reports list lot 1687292 as a Merck HPV vaccine, received between 2020-11-20 and 2023-07-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
59
Reports
0%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular2023%
General / Systemic (non-local)1517%
Neurological1315%
Gastrointestinal1012%
Thrombotic / Hematological89%
Injection-site / Local reaction78%
Musculoskeletal45%
Dermatological (non-injection-site)45%
Psychiatric / Neuropsychiatric33%
Allergic / Anaphylactic22%

Where reports came from

U.S. state of the reporter, where given (top 12).

California28
New York5
New Jersey4
Idaho2
Kentucky2
Pennsylvania2
Louisiana2
Massachusetts1
Oregon1
Georgia1
Ohio1
Washington1

Reports by month received

2020-111
2020-124
2021-015
2021-024
2021-034
2021-0427
2021-051
2021-064
2021-071
2021-082
2022-071
2022-102
2022-111
2023-031
2023-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.